Scanfil (STU:S0A) ROCE %: 13.50% (As of Mar. 2026)


STU:S0A Scanfil PLC STU:S0A
68 GF Score
Price €12.42
GF Value €9.43
Valuation Significantly Overvalued
! 8 Warning Signs
View Full Analysis

What is Scanfil ROCE %?

Scanfil STU:S0A -4.90% 68 ROCE % is 13.50% as of Mar. 2026. GuruFocus rates STU:S0A with a GF Score™ of 68/100 and a GF Value™ of €9.43 (Significantly Overvalued). The stock has 8 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Scanfil's annualized ROCE % for the quarter that ended in Mar. 2026 was 13.50%.


Scanfil  (STU:S0A) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.


Scanfil ROCE % Related Terms


Scanfil ROCE % Historical Data

* Premium members only.

The historical data trend for Scanfil's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Scanfil ROCE % Chart

Scanfil Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
ROCE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 15.55 15.45 22.34 16.45 14.77

Scanfil Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 13.36 15.35 14.72 18.39 13.50
STU:S0A
68GF Score
Scanfil PLC STU:S0A
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Scanfil ROCE % Calculation

Scanfil's annualized ROCE % for the fiscal year that ended in Dec. 2025 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=53.818/( ( (544.193 - 189.543) + (594.481 - 220.225) )/ 2 )
=53.818/( (354.65+374.256)/ 2 )
=53.818/364.453
=14.77 %

Scanfil's ROCE % of for the quarter that ended in Mar. 2026 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=57.2/( ( (594.481 - 220.225) + (774.7 - 301.4) )/ 2 )
=57.2/( ( 374.256 + 473.3 )/ 2 )
=57.2/423.778
=13.50 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of 13.50% mean?
Scanfil (STU:S0A) has a ROCE % of 13.50% as of Mar. 2026.
Is Scanfil's ROCE % too high?
Scanfil's current ROCE % is 13.50%. The Industrial Products industry median ROCE % is 7.08. Scanfil's value of 13.50% is 90.7% above this industry median. Overall, Scanfil has a GF Score™ of 68/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Scanfil's ROCE % compare to GEV and ETN?
Scanfil's ROCE % of 13.50% can be compared against companies in the Industrial Products industry. The industry median ROCE % is 7.08. Scanfil's value of 13.50% is 90.7% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for an Industrial Products company?
The median ROCE % among Industrial Products companies is 7.08, based on 3,026 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Scanfil's current ROCE % of 13.50% is 90.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Industrial Products industry, the median ROCE % is 7.08 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Scanfil's current ROCE % is 13.50%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Scanfil stock overvalued right now?
Based on GuruFocus' analysis, Scanfil (STU:S0A) is currently considered Significantly Overvalued. The stock's GF Value™ is €9.43, compared to a current price of €12.42 — trading 31.7% above its estimated fair value. The current ROCE % is 13.50% and 90.7% above the Industrial Products industry median of 7.08. Scanfil's overall GF Score™ is 68/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Scanfil (STU:S0A), the current ROCE % is 13.50% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Scanfil (STU:S0A) Overvalued in 2026?

Based on GuruFocus' analysis, Scanfil stock appears to be overvalued. The current stock price of €12.42 is trading 31.7% above its estimated GF Value™ of €9.43. GuruFocus considers Scanfil to be Significantly Overvalued.

Key valuation signals for STU:S0A:

  • ROCE %: 13.50%
  • GF Value™: €9.43 vs. price of €12.42 (31.7% above fair value)
  • GF Score™: 68/100 with 8 warning signs
  • Industry Position: 90.7% above the Industrial Products median

No single metric tells the full story. See the STU:S0A stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Scanfil Business Description

Other Exchanges 0Q59:UKSCANFL:Finland
Address Yritystie 6, Sievi, FIN, 85410
Scanfil PLC is an international contract manufacturer and system supplier for the electronics industry, providing services ranging from product design to manufacturing, material procurement, and logistics solutions. The Company's services include design services, prototype manufacturing, design for manufacturability (DFM), test development, supply chain and logistics services, circuit board assembly, manufacturing of subsystems and components, and complex systems integration. It serves the sector across Aerospace & Defense, Energy & Cleantech, Industrial, and Medtech & Life Science. The Company operates in the Americas, APAC, Central Europe, and Northern Europe, with Central Europe generating the majority of revenue.
68GF Score

Get the complete analysis for STU:S0A

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€12.42
Price
€9.43
GF Value